Media Centre

Text with Title

Evaluate's commercial intelligence on the pharmaceutical, biotechnology, and medical device industries is consistently referenced by leading business and industry publications such as the Financial Times, Wall Street Journal, and Nature.

Download our latest Media Kit for a forward-looking view of top companies, products, and more to support your editorial content.

Media Kit

To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us.

Jennifer Dinkel, Evaluate
Media & general questions

Latest Media Coverage

R&D Magazine

The Marriage of Big Pharma and Biotech

Moreover, biotechnology drugs are contributing to sales at a large scale. For EvaluatePharma, these products will represent 31 percent of the market in 2024 in comparison…

Nature Reviews Drug Discovery

The fragmentation of biopharmaceutical innovation

In the pharmaceutical industry, there are typically 50–120 consolidative deals each year through which two companies become a single entity. So, it could be reasonable to…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.